Article

Sponsored Content

Mass Spectrometry Imaging: Top 8 benefits in oncology drug discovery and development

Author(s):

Mass spectrometry imaging (MSI) is beneficial in early development and murine models across many therapeutic areas. This technique is especially suited for oncology due to the availability of tissue.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.